Lalitha C, Shwetha S, and Asha G S: Assessment of clinical and etiological factors in nail dyschromias


Introduction

Nail abnormalities can be a revealing sign of a systemic disease. Nail dyschromia or chromonychia is defined as an abnormality in the color of the substance or the surface of the nail plate or subungual tissue.1 The discoloration specifically due to the deposition of melanin is labeled as nail pigmentation.1 Melanonychia, as a variant, is defined as brown or black pigmentation of nails.1, 2

Nails of both limbs should be always examined in totality apart from the affected nail, preferably prior to the examination of the affected nail to avoid bias. However, prior to this, a detailed history is necessary, especially to rule out presence of any exogenously added pigmentation of the nail (e.g. Henna). When the discoloration is secondary to exogenous agents, the pattern lies along the curve of the proximal nail fold; if internal, follows the curve of the lunula.2

A working anatomical knowledge of the nail, its attachments and the underlying tissues is imperative to analyze the factors that cause discoloration of an otherwise transparent nail.1 A systemic disease can affect one or all nails simultaneously, but a localized affect can alter the colour of the one or two nails maximally, limiting the involvement.2 In addition, a quick but thorough cutaneous and mucosal examination is desired as these may many a times provide an important clue to an underlying disease. Few morphological changes might occur otherwise in an apparently normal healthy individual. An idea of this may help avert unnecessary work up in these individuals. 3

There can be several causes of Melanonychia, a brief description of which is mentioned in Figure 1.

Materials and Methods

The aim of the study is to find out the different causes of nail dyschromias. It was a cross sectional study done from April 2015 to July 2015 at tertiary hospital in Bangalore. 200 patients above the age of 18 years, presenting with nail discoloration were included in the study. A detailed history including occupation, hobbies, and illnesses (systemic and dermatological), medications, past treatments, family history, trauma to the nail, type of footwear, manicure and pedicure treatment was noted in a semi structured pro forma.

Routine blood investigations like Complete hemogram with peripheral smear, Liver function test, renal function test, Random blood sugar, ELISA for HIV 1 & 2, Serum Vitamin B12 were done. Wherever deemed necessary, a nail biopsy and scrapings was performed.

The data was then entered in an MS excel spreadsheet. The statistical analysis was done using SPSS v21. The categorical data was represented as frequencies and proportions, while the quantitative data was represented as mean, median and IQR.

Results

115 (57.5%) were males and 85 (42.05%) were females (Figure 22).

More than 50% patients were in the age group between 30 to 50 years (Figure 23).

Laborers constituted the highest portion amongst the study participants, followed closely by computer operators.(Figure 24)

On analysis of the lab parameter, 22.5% participants had Hb less than 8 gm/dL. 12.3% of the study participants had serum creatinine more than 2.0 mg/L. Deranged liver function was observed in 12.45% participants. ELISA done for HIV I and II was reactive in 48.02% of the study participants with melanonychia. Vitamin B12 deficiency was observed in 14.12% of the study participants with melanonychia (Figure 25).

The most seen nail dyschromia in this study was melanonychia (86.5%) followed by leukonychia (5%), blue chromonychia (5%), yellow chromonychia (1.5%) and 0.5% of other color chromonychia (orange exogenous henna nail discoloration and one green nail associated with). Longitudinal Melanonychia, was the most seen, transverse, and subtotal melanonychia were seen in few cases (Figure 26). It involved both fingernails and toenails (fingernails> toenails). In fingernails, it was seen more in thumbnails and index and middle fingers and in toe nails, Great toe nail involvement was observed. The different types of nail dyschromias photographs are shown in figures (Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8, Figure 9, Figure 10, Figure 11, Figure 12, Figure 13, Figure 14, Figure 15, Figure 16, Figure 17, Figure 18, Figure 19, Figure 20, Figure 21).

Figure 1

Causes of melanonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image1.png
Figure 2

Melanonychia in HIV patient

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image2.png
Figure 3

Melanonychia caused by Zidovudine

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image3.png
Figure 4

Terry’s nails

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image4.png
Figure 5

Physiological melanonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image5.png
Figure 6

Melanonychia in psoriasis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image6.png
Figure 7

Doxorubicin induced blue chromonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image7.png
Figure 8

Cyclophosphamide induce chromonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image8.png
Figure 9

Fungal melanonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image9.png
Figure 10

Fungal Brown chromonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image10.png
Figure 11

Orange chromonychia (exogenous due to henna)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image11.png
Figure 12

Melanonychia due to lichen planus

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image12.png
Figure 13

Melanonychia due to pemphigus with onychomadesis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image13.png
Figure 14

Systemic lupus erythematosus and antimalarial induced pigmentation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image14.png
Figure 15

Melonachia in Dystrophic epidermolysis bullosa patient

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image15.png
Figure 16

Traumatic blackish nail discoloration

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image16.png
Figure 17

Bleomycyin induced nail pigmentation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image17.png
Figure 18

Melanonychia with crescent leuchonychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image18.png
Figure 19

Punctate leuconychia

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image19.png
Figure 20

Vitamin B12 deficiency nails with pigmentation in palmar creases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image20.png
Figure 21

Longitudinal erythronychia with V nicking of nails in darier’s disease

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image21.png
Graph 1

Male and female distribution

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image22.png

Graph 2

Age distribution

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image23.png

Graph 3

Occupation of the patients

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image24.png

Graph 4

Different causes of dyschromias

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image25.png

Graph 5

Types of dyschromias

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/aa6e5e74-3268-4567-93d5-85c989b94454image26.png

Discussion

Nail dyschromias as a common disorder encountered by dermatologists, even general practitioners, on a day-to-day basis. This is secondary to pigmentation of the nail bed or plate and can be attributed to various endogenous (localized or systemic) or exogenous causes. The type of the nail dyschromia depends on the pigment deposited, the region and its duration.

In this study, majority of the patients belonged to the age brackets of 30-50 years. This was like the findings in a study done by Soo Hyeon Bae et al, the mean age was 43.6 ± 23.8 years. 57.5% of the patients were male, which was like the findings by Soo Hyeon Bae et al.4

Hobbies play an important role in the identification of the cause of nail dyschromia, as they contribute as an exogenous factor. In our study, we found that sports was the most common hobby amongst the study participants. This was like the findings in a study done by Yildirimer L et al,5 where injuries due to sports related trauma (crush injuries) was a leading cause of nail dyschromia.

Anaemia is one of the causes of apparent leukonychia, a cause of nail dyschromia. In our study we found that 22.5% patients had anaemia. In a study by Braun et al, 6 anaemia was observed in those with leukonychia, due to blanching of the nail bed. In a study done by Soo Hyeon Bae et al, 4 incidence of anaemia was 38.5%. Half and half nails can be seen with those with deranged liver function, however in this study we didn’t report any such case in those patients with raised bilirubin. Chronic renal failure can also cause nail dyschromias, in this study 12.3% participants had raised serum creatinine. In a study done by Soo Hyeon Bae et al, 4 15.4% patients had chronic renal failure.

Melanonychia was the most common dyschromia (85.5%) seen in this study. In the present study, drug induced and systemic infection like HIV contributed largely to melanonychia whereas local and dermatological conditions contributed to few. This is in accordance with other studies done on nail pigmentations.

Among the drug induced, 30% were due to antiretroviral drugs like zidovudine, lamivudine, others were due chemotherapatic agents and antimalarials. This can be attributed to the cause that our institute was referral centre for HIV and ART centre. In this study, we did not find any subungual melanoma or naevus or wart presenting with melanonychia. However, in a study done by Soo Hyeon Bae et al, 33.3% patients had naevus of the nail matrix.

In this, we observed 10 cases (5%) of blue nails, which was due to chemotherapeutic medication like doxorubicin, cyclophosphamide and antimalarials. In a study done by Soo Hyeon Bae et al, blue nails was seen only in a small percentage of the study population (1.3%). In a study done by P F Levey and team 7 in Africans, they found that HIV infection and the treatment is a cause for blue nails. Yellow discoloration of nails (5 in number) was seen in 2 cases of onychomycosis and in 3 cases of jaundice due to liver disorder. In a study by Brzeziński P et al,8 the cause of the yellow nail discoloration was due to chronic pulmonary disease. Similar findings were recorded by Piraccini and team.9 We found one case each on longitudinal erythronychia in Darier’s disease, green nails due to pseudomonas infection and orange discoloration of nails due to henna.

Conclusion

Nail being a small apparatus can reveal underlying systemic or local disorders. It’s important to examine nail routinely and worked up with detailed history and investigations

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Source of Funding

None.

References

1 

M Jeanmougin J Civatte Nail DyschromiaInt J Dermatol198322527990

2 

V Mendiratta A Jain Nail Symposium-Nails Part IIndian J Dermatol Venereol Leprol2011776652810.4103/0378-6323.86473

3 

R Baran R P Dawber R Baran RP Dawber E Hanche Physical scienceDiseases of the nail and its management Blackwell ScienceLondon200185103

4 

SH Bae SH Jang YH Won Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia AreataAnn Dermatol20193133596110.5021/ad.2019.31.3.359

5 

L Yildirimer Experience of nail bed injuries at a tertiary hand trauma unit: A 12-month review and cost analysisJ Hand Surg20194444192310.1177/1753193419826465

6 

R P Braun R Baran F A Le Gal S Dalle S Ronger R Pandolfi Diagnosis and management of nail pigmentationJ Am Acad Dermatol20075658354710.1016/j.jaad.2006.12.021

7 

P F Levay M E Botes E Malela Dyschromonychia: clinical significance in a South African populationSA Fam Pract2005479549

8 

P Brzeziński M Bury E Jagiełło-Wieczorek Coexistence yellow nail syndrome with systemic symptomsN Dermatol Online201012158

9 

B M Piraccini B Urciuoli M Starace A Tosti R Balestri Yellow nail syndrome: Clinical experience in a series of 21 patientsJ Dtsch Dermatol Ges20141221317



jats-html.xsl

© This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


  • Article highlights
  • Article tables
  • Article images

Article History

Received : 16-09-2021

Accepted : 21-10-2021

Available online : 13-12-2021


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2021.061


Article Metrics






Article Access statistics

Viewed: 158

PDF Downloaded: 56



Open Abstract (Increase article citation) Wiki in hindi